Cigarette smoke up-regulates PDE3 and PDE4 to decrease cAMP in airway cells.

Area of Science:

• Cellular Biology
• Respiratory Medicine
• Pharmacology

Background:

• Cyclic adenosine monophosphate (cAMP) is a critical second messenger regulating cell function and implicated in disease pathophysiology.
• Chronic obstructive pulmonary disease (COPD), often caused by cigarette smoke (CS), is targeted by therapies that modulate cAMP pathways through phosphodiesterase (PDE) inhibition.
• Understanding how CS disrupts cAMP signaling in airway cells, particularly through endogenous PDEs, remains limited.

Purpose of the Study:

• To investigate the effects of cigarette smoke (CS) exposure on cAMP signaling dynamics in airway cells.
• To explore the role of phosphodiesterases (PDEs) in CS-induced alterations of cAMP levels.
• To assess the functional consequences of altered cAMP signaling on airway smooth muscle and ciliary function.

Main Methods:

• Utilized a novel Förster resonance energy transfer (FRET)-based cAMP biosensor.
• Applied the biosensor in vivo in mice, ex vivo in precision cut lung slices (PCLS), and in vitro in human cell models.
• Tracked real-time cAMP dynamics following CS exposure and stimulation with PDE inhibitors (cilostamide, rolipram) and agonists (fenoterol).

Main Results:

• CS exposure, in vivo and ex vivo, increased FRET responses to PDE inhibitors cilostamide and rolipram, indicating elevated PDE activity.
• Elevated FRET signals for rolipram correlated with increased protein expression of PDE4 subtypes.
• In CS-exposed PCLS, rolipram restored ciliary beating frequency, while cilostamide enhanced airway relaxation.

Conclusions:

• Cigarette smoke exposure up-regulates both PDE3 and PDE4 expression and activity in airway cells.
• These PDE alterations significantly impact real-time cAMP dynamics.
• The disruption of cAMP signaling by CS-induced PDE changes contributes to the pathophysiology of CS-induced lung diseases like COPD.